<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0355">
 <label>71</label>
 <element-citation publication-type="journal" id="rf0280">
  <person-group person-group-type="author">
   <name>
    <surname>Levet</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Rosi√®re</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Merlos</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Fusaro</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Berger</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Amighi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Wauthoz</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Development of controlled-release cisplatin dry powders for inhalation against lung cancers</article-title>
  <source>Int. J. Pharm.</source>
  <volume>515</volume>
  <year>2016</year>
  <fpage>209</fpage>
  <lpage>220</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijpharm.2016.10.019</pub-id>
  <pub-id pub-id-type="pmid">27737810</pub-id>
 </element-citation>
</ref>
